AI assistant
Aggreko Plc — Director's Dealing 2018
May 29, 2018
74738_rns_2018-05-29_59a1e0b0-4cf9-486e-9105-08d59b84f1ca.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 5144P
Aggreko PLC
29 May 2018
29 May 2018
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
The notification made on behalf of Persons Discharging Managerial Responsibility ('PDMRs') under article 19.1 of the Market Abuse Regulation ('MAR') relates to a transaction made on behalf of Uwe Krueger, a PDMR, in Aggreko plc shares.
This announcement is made in accordance with Article 19.3 of MAR
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Uwe Krueger
2
Reason for the notification
a)
Position/status
Non-executive Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Aggreko plc
b)
LEI
2138003R7TGCSVF27H47
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary shares of 4 329/395 pence each ('Shares')
GB00BK1PTB77
b)
Nature of the transaction
Acquisition of Shares under a Dividend Re-Investment Plan (DRIP) following the dividend payment on 22 May 2018.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £7.48 | 71 |
d)
Aggregated information
- Aggregated volume
- Price
71
£7.48
e)
Date of the transaction
22 May 2018
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHGMGZKRLKGRZG